Dual treatment of albendazole in hepatic hydatidosis: New therapeutic modality in 52 cases


Polat C., Dervisoglu A., Hokelek M. , Yetim I., Buyukkarabacak Y., Ozkutuk Y., ...Daha Fazla

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.20, ss.421-425, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20 Konu: 3
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1111/j.1440-1746.2004.03535.x
  • Dergi Adı: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • Sayfa Sayıları: ss.421-425

Özet

Background: Hepatic hydatidosis still remains as a serious problem in general surgery. Recurrence and/or secondary hydatidosis rates are up to 25% in the cases treated with surgery alone. Albendazole is the most commonly used drug in the medical treatment of echinococcosis. The aim of the present study was to evaluate the effect of albendazole using the intraoperative and perioperative periods as dual therapy.